Spotlight on EBE’s Biotherapeutics Working Group

For our final spotlight blog, we are delighted to feature our Biotherapeutics Working Group, which will have their last get-together of the year today. This working group originally focused on biosimilars and related regulatory challenges, but it eventually expanded to include all biotherapeutics, including innovative therapeutics, for example antibodies, and how they are regulated. Biologic [...]